Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,632.19
(
-0.61%
)
US TECH 100
23,946.80
(
0.83%
)
Dow Jones
46,558.47
(
0.00%
)
Brent Oil
100.64
(
-0.59%
)
Bitcoin
73,625.35
(
1.12%
)
News Focus
News Focus
Post# of 257244
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122787
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 151483

Tuesday, 10/30/2012 10:01:14 PM

Tuesday, October 30, 2012 10:01:14 PM

Post# of 257244
AGN is aware of this problem; from the 3Q12 CC:

http://seekingalpha.com/article/962971-allergan-management-discusses-q3-2012-results-earnings-call-transcript

Since the last earnings report, we have trained 200 more individual physicians. Focus is now on deepening the level of training…rather than just training de novo injectors…

Our investments in both branded and non-branded DTC campaigns for BOTOX for chronic migraine are driving patients to our websites for information about the condition and also where to find a headache specialist… We are pleased that, in the recent physician survey, Allergan is now perceived as the #1 company in migraine management by physicians.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now